Catalog

In older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities, with pneumococci remaining the leading cause of bacteria infection. More concerning is the effect pneumococcal infections can have when they breach the lungs and become invasive. Pneumococcal meningitis is the most frequent and severe suppurative complication associated with pneumococcal bacteremia. Even with appropriate antimicrobial treatment, pneumococcal meningitis has a mortality rate of 20 to 30 percent. Luckily, the increased rates of vaccination and serotypes covered by various vaccines have caused significant reductions in the incidence of invasive pneumococcal disease (IPD). Clinicians treating those at risk of pneumococcal pneumonia and IPD require focused education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, guideline updates, and information on recent approvals and evidence.

In older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities, with pneumococci remaining the leading cause of bacteria infection. More concerning is the effect pneumococcal infections can have when they breach the lungs and become invasive. Pneumococcal meningitis is the most frequent and severe suppurative complication associated with pneumococcal bacteremia. Even with appropriate antimicrobial treatment, pneumococcal meningitis has a mortality rate of 20 to 30 percent. Luckily, the increased rates of vaccination and serotypes covered by various vaccines have caused significant reductions in the incidence of invasive pneumococcal disease (IPD). Clinicians treating those at risk of pneumococcal pneumonia and IPD require focused education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, guideline updates, and information on recent approvals and evidence.

Recently, a team of researchers at the NCCPA examined the impact of educational debt on PA specialty selection - tune in as we discuss their work as recently published in JAAPA. We know that the decision to specialize is nuanced, involving a PAs individual goals, experiences in PA school, job availability for each physical location, compensation, and levels of debt accrued in training. Listen as Andrez Kozikowski, Alicia Quella, and Mirela Bruza-Augatis discuss this important topic.

Designed specifically for new graduate Physician Associates, this course offers an in-depth exploration of essential topics that go beyond the textbooks. Bringing together content from past conferences, we cover key areas including effective job search strategies, leveraging AI tools to enhance patient care, managing overnight patient care, promoting personal well-being, navigating PA state advocacy, and making a meaningful impact in the profession. Additionally, we explore what the textbooks don’t teach you in emergency medicine, providing practical, real-world insights every new PA should know. This course will equip you with the knowledge and skills to thrive in your PA career.

Osteoporosis, the most common bone disease, is associated with significant morbidity and mortality in older women and men. Fractures related to osteoporosis occur in both women and men, at a total of approximately 2 million fractures per year. Though osteoporosis has a significant impact on older Americans, it remains under-diagnosed. This educational program will focus on diagnostic guidelines, appropriate pharmacologic recommendations, and treatment monitoring. PAs who participate in this program will be better able to diagnose patients with osteoporosis and recognize the impact of the disease. These PAs will also be more prepared to assess the clinical safety and efficacy profiles of pharmacologic therapies and select appropriate agents for patients with osteoporosis. Additionally, PAs will be better prepared to monitor patients who receive treatment for osteoporosis, including in the assessment of treatment response.

This presentation explores the value of PAs in healthcare, examining key components that contribute to patient outcomes and employer benefits. Participants will analyze evidence supporting PA value, assess methods of measurement, and discuss limitations that may underestimate their impact. By understanding these factors, PAs will be better equipped to demonstrate their contributions effectively to employers, colleagues, and the healthcare system as a whole.

This presentation provides PAs with a comprehensive overview of healthcare reimbursement, including evolving payment models and value-based care. Participants will explore key Medicare billing policies, such as “incident to” and “shared visit” billing, as well as essential enrollment and credentialing requirements for payer reimbursement. By understanding these critical financial and regulatory aspects, PAs can optimize billing practices, maximize reimbursement, and enhance the financial sustainability of their clinical practice.

Osteoporosis, the most common bone disease, is associated with significant morbidity and mortality in older women and men. Fractures related to osteoporosis occur in both women and men, at a total of approximately 2 million fractures per year. Though osteoporosis has a significant impact on older Americans, it remains under-diagnosed. This educational program will focus on diagnostic guidelines, appropriate pharmacologic recommendations, and treatment monitoring. PAs who participate in this program will be better able to diagnose patients with osteoporosis and recognize the impact of the disease. These PAs will also be more prepared to assess the clinical safety and efficacy profiles of pharmacologic therapies and select appropriate agents for patients with osteoporosis. Additionally, PAs will be better prepared to monitor patients who receive treatment for osteoporosis, including in the assessment of treatment response.

Osteoporosis, the most common bone disease, is associated with significant morbidity and mortality in older women and men. Fractures related to osteoporosis occur in both women and men, at a total of approximately 2 million fractures per year. Though osteoporosis has a significant impact on older Americans, it remains under-diagnosed. This educational program will focus on diagnostic guidelines, appropriate pharmacologic recommendations, and treatment monitoring. PAs who participate in this program will be better able to diagnose patients with osteoporosis and recognize the impact of the disease. These PAs will also be more prepared to assess the clinical safety and efficacy profiles of pharmacologic therapies and select appropriate agents for patients with osteoporosis. Additionally, PAs will be better prepared to monitor patients who receive treatment for osteoporosis, including in the assessment of treatment response.

The 2025 Standards of Care in Diabetes includes all the American Diabetes Association’s (ADA) current clinical practice recommendations and is intended to provide clinicians, patients, researchers, payers, and others with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. The recommendations are based on an extensive review of the clinical diabetes literature, supplemented with input from ADA staff and the medical community at large. The Standards of Care in Diabetes is updated annually, or more frequently online if new evidence or regulatory changes merit immediate incorporation and is published in Diabetes Care. Join us to hear first-hand updates to the 2025 Standards of Care guidelines.